Drug Trial Radar · NCT05296356
OSU6162 in Bipolar Depression (OBID)
Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
22
Planned (sponsor's estimate)
Start
Oct 25, 2021
Primary completion
May 31, 2029
Study completion May 31, 2029
Sponsor
- Lead sponsor
- Göteborg UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Arvid Carlsson Research AB
- First posted
- Mar 25, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An explorative, open label, single armed, flexible dose, single center, phase IIa study of 8 weeks, initiated in subjects with bipolar depression. The study will consist of 9 visits and 1 safety visit. Subjects with a primary diagnosis of bipolar disorder (type 1 or 2) currently in an acute depressive phase (i.e. bipolar depression) and being on stable medication with at least one mood stabilizer.
Conditions
- Bipolar Depression
Interventions
OSU6162Drug
OSU6162
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in the Montgomery-Åsberg Depression Rating Scale (MADRS) at endpoint [Day 60].Time frame: Endpoint at 60 days treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sahlgrenska university hospital/Östra
Gothenburg, Sweden · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.